Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism

John G. Nutt, Steven A. Gunzler, Trish Kirchhoff, Penelope Hogarth, Jerry L. Weaver, Michael Krams, Brenda Jamerson, Frank S. Menniti, Jaren W. Landen

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism'. Together they form a unique fingerprint.

Medicine & Life Sciences